Stock Information
BridgeBio Pharma Inc (BBIO)
Ticker Symbol: BBIO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $12,811.28 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.7841
Revenue (TTM): $2.59 M
Dividend Yield: N/A%
ROE: -206.74%
Latest News
-
Ascendis Pharma: Yuviwel Approved Despite Legal Challenges
Tue, Mar 3, 2026 12:05 PM
-
Ionis Pharmaceuticals: Digesting Recent Events
Fri, Feb 27, 2026 2:54 AM
-
Truist Securities Maintains Buy on BridgeBio Pharma, Raises Price Target to $95
Wed, Feb 25, 2026 1:57 PM
-
Oppenheimer Maintains Outperform on BridgeBio Pharma, Lowers Price Target to $81
Wed, Feb 25, 2026 1:41 PM
-
Morgan Stanley Maintains Overweight on BridgeBio Pharma, Raises Price Target to $98
Wed, Feb 25, 2026 11:32 AM
-
Evercore ISI Group Maintains Outperform on BridgeBio Pharma, Raises Price Target to $125
Wed, Feb 25, 2026 10:16 AM
-
BridgeBio Pharma shares are trading higher after the company reported better-than-expected Q4 sales results.
Wed, Feb 25, 2026 10:04 AM
Key Financials
Financial data not available
